✦ LIBER ✦

Phase II Clinical Trial Data with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib (OSI-774) in Non–Small-Cell Lung Cancer

✍ Scribed by Romàn Pérez-Soler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib (OSI-774, Tarceva™), a Selecti

✍ Mary Hightower; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 78 KB

Update of epidermal growth factor recept

✍ Chen, Yuh-Min 📂 Article 📅 2013 🏛 Elsevier Science 🌐 Chinese ⚖ 720 KB

Select Clinical Trials of Erlotinib (OSI

✍ L. Minerva Burgos Fuster; Alan B. Sandler 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 330 KB

Overview of clinical trials with epiderm

✍ Melodie Thomas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 728 KB

Epidermal Growth Factor Receptor Tyrosin

✍ Jamal-Hanjani, M.; Spicer, J. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 320 KB

Pharmacodynamic Separation of Epidermal

✍ Angela M. Davies; Cheryl Ho; Primo N. Lara Jr; Philip Mack; Paul H. Gumerlock; D 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 166 KB